Skip to main content
NCBI home page
Sexually Transmitted Infections logoLink to Sexually Transmitted Infections
. 2001 Aug;77(4):232–237. doi: 10.1136/sti.77.4.232

Sorting out the new HSV type specific antibody tests

R Ashley 1
PMCID: PMC1744343  PMID: 11463920

Abstract

This review will delineate performance characteristics and limitations, as far as they are known, of the new glycoprotein G based, type specific HSV serologies. Several of these tests have been FDA approved in the United States for use in adults. With the departure of Gull/Meridian from the HSV serology market, it is important for clinicians to understand the sources and claims of the remaining type specific tests. Moreover, inaccurate tests using crude antigen preparations remain on the market. These tests are identified based on product insert information provided by company representatives.

Key Words: herpes; antibodies; serology

Full Text

The Full Text of this article is available as a PDF (89.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arvaja M., Lehtinen M., Koskela P., Lappalainen M., Paavonen J., Vesikari T. Serological evaluation of herpes simplex virus type 1 and type 2 infections in pregnancy. Sex Transm Infect. 1999 Jun;75(3):168–171. doi: 10.1136/sti.75.3.168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ashley R. L., Corey L. HSV type specific antibody tests: patients are ready, are clinicians? Genitourin Med. 1997 Aug;73(4):235–236. doi: 10.1136/sti.73.4.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ashley R. L., Eagleton M. Evaluation of a novel point of care test for antibodies to herpes simplex virus type 2. Sex Transm Infect. 1998 Jun;74(3):228–229. [PubMed] [Google Scholar]
  4. Ashley R. L., Eagleton M., Pfeiffer N. Ability of a rapid serology test to detect seroconversion to herpes simplex virus type 2 glycoprotein G soon after infection. J Clin Microbiol. 1999 May;37(5):1632–1633. doi: 10.1128/jcm.37.5.1632-1633.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ashley R. L., Militoni J., Lee F., Nahmias A., Corey L. Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J Clin Microbiol. 1988 Apr;26(4):662–667. doi: 10.1128/jcm.26.4.662-667.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ashley R. L., Militoni J. Use of densitometric analysis for interpreting HSV serologies based on Western blot. J Virol Methods. 1987 Nov;18(2-3):159–168. doi: 10.1016/0166-0934(87)90121-2. [DOI] [PubMed] [Google Scholar]
  7. Ashley R. L., Wald A., Eagleton M. Premarket evaluation of the POCkit HSV-2 type-specific serologic test in culture-documented cases of genital herpes simplex virus type 2 [see comment]. Sex Transm Dis. 2000 May;27(5):266–269. doi: 10.1097/00007435-200005000-00005. [DOI] [PubMed] [Google Scholar]
  8. Ashley R. L., Wald A. Genital herpes: review of the epidemic and potential use of type-specific serology. Clin Microbiol Rev. 1999 Jan;12(1):1–8. doi: 10.1128/cmr.12.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ashley R. L., Wu L., Pickering J. W., Tu M. C., Schnorenberg L. Premarket evaluation of a commercial glycoprotein G-based enzyme immunoassay for herpes simplex virus type-specific antibodies. J Clin Microbiol. 1998 Jan;36(1):294–295. doi: 10.1128/jcm.36.1.294-295.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ashley R., Cent A., Maggs V., Nahmias A., Corey L. Inability of enzyme immunoassays to discriminate between infections with herpes simplex virus types 1 and 2. Ann Intern Med. 1991 Oct 1;115(7):520–526. doi: 10.7326/0003-4819-115-7-520. [DOI] [PubMed] [Google Scholar]
  11. Bernstein D. I., Lovett M. A., Bryson Y. J. Serologic analysis of first-episode nonprimary genital herpes simplex virus infection. Presence of type 2 antibody in acute serum samples. Am J Med. 1984 Dec;77(6):1055–1060. doi: 10.1016/0002-9343(84)90188-8. [DOI] [PubMed] [Google Scholar]
  12. Brown Z. A. HSV-2 specific serology should be offered routinely to antenatal patients. Rev Med Virol. 2000 May-Jun;10(3):141–144. doi: 10.1002/(sici)1099-1654(200005/06)10:3<141::aid-rmv280>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  13. Brown Z. A., Selke S., Zeh J., Kopelman J., Maslow A., Ashley R. L., Watts D. H., Berry S., Herd M., Corey L. The acquisition of herpes simplex virus during pregnancy. N Engl J Med. 1997 Aug 21;337(8):509–515. doi: 10.1056/NEJM199708213370801. [DOI] [PubMed] [Google Scholar]
  14. Brugha R., Brown D., Meheus A., Renton A. Should we be screening for asymptomatic HSV infections? Sex Transm Infect. 1999 Jun;75(3):142–144. [PubMed] [Google Scholar]
  15. Corey L., Handsfield H. H. Genital herpes and public health: addressing a global problem. JAMA. 2000 Feb 9;283(6):791–794. doi: 10.1001/jama.283.6.791. [DOI] [PubMed] [Google Scholar]
  16. Cusini M., Cusan M., Parolin C., Scioccati L., Decleva I., Mengoli C., Suligoi B., Palú G. Seroprevalence of herpes simplex virus type 2 infection among attendees of a sexually transmitted disease clinic in Italy. Italian Herpes Forum. Sex Transm Dis. 2000 May;27(5):292–295. doi: 10.1097/00007435-200005000-00011. [DOI] [PubMed] [Google Scholar]
  17. Diamond C., Selke S., Ashley R., Benedetti J., Corey L. Clinical course of patients with serologic evidence of recurrent genital herpes presenting with signs and symptoms of first episode disease. Sex Transm Dis. 1999 Apr;26(4):221–225. doi: 10.1097/00007435-199904000-00007. [DOI] [PubMed] [Google Scholar]
  18. Eis-Hübinger A. M., Däumer M., Matz B., Schneweis K. E. Evaluation of three glycoprotein G2-based enzyme immunoassays for detection of antibodies to herpes simplex virus type 2 in human sera. J Clin Microbiol. 1999 May;37(5):1242–1246. doi: 10.1128/jcm.37.5.1242-1246.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Fairley I., Monteiro E. F. Patient attitudes to type specific serological tests in the diagnosis of genital herpes. Genitourin Med. 1997 Aug;73(4):259–262. doi: 10.1136/sti.73.4.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Fleming D. T., McQuillan G. M., Johnson R. E., Nahmias A. J., Aral S. O., Lee F. K., St Louis M. E. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med. 1997 Oct 16;337(16):1105–1111. doi: 10.1056/NEJM199710163371601. [DOI] [PubMed] [Google Scholar]
  21. Fleming D. T., Wasserheit J. N. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect. 1999 Feb;75(1):3–17. doi: 10.1136/sti.75.1.3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Groen J., Van Dijk G., Niesters H. G., Van Der Meijden W. I., Osterhaus A. D. Comparison of two enzyme-linked immunosorbent assays and one rapid immunoblot assay for detection of herpes simplex virus type 2-specific antibodies in serum. J Clin Microbiol. 1998 Mar;36(3):845–847. doi: 10.1128/jcm.36.3.845-847.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Handsfield H. H., Stone K. M., Wasserheit J. N. Prevention agenda for genital herpes. Sex Transm Dis. 1999 Apr;26(4):228–231. doi: 10.1097/00007435-199904000-00009. [DOI] [PubMed] [Google Scholar]
  24. Handsfield HH. Public Health Strategies to Prevent Genital Herpes: Where Do We Stand? Curr Infect Dis Rep. 2000 Feb;2(1):25–30. doi: 10.1007/s11908-000-0084-y. [DOI] [PubMed] [Google Scholar]
  25. Hashido M., Lee F. K., Inouye S., Kawana T. Detection of herpes simplex virus type-specific antibodies by an enzyme-linked immunosorbent assay based on glycoprotein G. J Med Virol. 1997 Dec;53(4):319–323. doi: 10.1002/(sici)1096-9071(199712)53:4<319::aid-jmv2>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  26. Ho D. W., Field P. R., Irving W. L., Packham D. R., Cunningham A. L. Detection of immunoglobulin M antibodies to glycoprotein G-2 by western blot (immunoblot) for diagnosis of initial herpes simplex virus type 2 genital infections. J Clin Microbiol. 1993 Dec;31(12):3157–3164. doi: 10.1128/jcm.31.12.3157-3164.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Ho D. W., Field P. R., Sjögren-Jansson E., Jeansson S., Cunningham A. L. Indirect ELISA for the detection of HSV-2 specific IgG and IgM antibodies with glycoprotein G (gG-2). J Virol Methods. 1992 Mar;36(3):249–264. doi: 10.1016/0166-0934(92)90056-j. [DOI] [PubMed] [Google Scholar]
  28. Johnson R. E., Nahmias A. J., Magder L. S., Lee F. K., Brooks C. A., Snowden C. B. A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States. N Engl J Med. 1989 Jul 6;321(1):7–12. doi: 10.1056/NEJM198907063210102. [DOI] [PubMed] [Google Scholar]
  29. Kinghorn G. R. Type-specific serological testing for herpes simplex infection. Int J STD AIDS. 1998 Sep;9(9):497–500. doi: 10.1258/0956462981922674. [DOI] [PubMed] [Google Scholar]
  30. Koutsky L. A., Stevens C. E., Holmes K. K., Ashley R. L., Kiviat N. B., Critchlow C. W., Corey L. Underdiagnosis of genital herpes by current clinical and viral-isolation procedures. N Engl J Med. 1992 Jun 4;326(23):1533–1539. doi: 10.1056/NEJM199206043262305. [DOI] [PubMed] [Google Scholar]
  31. Krone M. R., Wald A., Tabet S. R., Paradise M., Corey L., Celum C. L. Herpes simplex virus type 2 shedding in human immunodeficiency virus-negative men who have sex with men: frequency, patterns, and risk factors. Clin Infect Dis. 2000 Feb;30(2):261–267. doi: 10.1086/313647. [DOI] [PubMed] [Google Scholar]
  32. Lafferty W. E., Downey L., Celum C., Wald A. Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention. J Infect Dis. 2000 Apr 13;181(4):1454–1457. doi: 10.1086/315395. [DOI] [PubMed] [Google Scholar]
  33. Langenberg A. G., Corey L., Ashley R. L., Leong W. P., Straus S. E. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. N Engl J Med. 1999 Nov 4;341(19):1432–1438. doi: 10.1056/NEJM199911043411904. [DOI] [PubMed] [Google Scholar]
  34. Langenberg A., Benedetti J., Jenkins J., Ashley R., Winter C., Corey L. Development of clinically recognizable genital lesions among women previously identified as having "asymptomatic" herpes simplex virus type 2 infection. Ann Intern Med. 1989 Jun 1;110(11):882–887. doi: 10.7326/0003-4819-110-11-882. [DOI] [PubMed] [Google Scholar]
  35. Lee F. K., Coleman R. M., Pereira L., Bailey P. D., Tatsuno M., Nahmias A. J. Detection of herpes simplex virus type 2-specific antibody with glycoprotein G. J Clin Microbiol. 1985 Oct;22(4):641–644. doi: 10.1128/jcm.22.4.641-644.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Lee F. K., Pereira L., Griffin C., Reid E., Nahmias A. A novel glycoprotein for detection of herpes simplex virus type 1-specific antibodies. J Virol Methods. 1986 Sep;14(2):111–118. doi: 10.1016/0166-0934(86)90041-8. [DOI] [PubMed] [Google Scholar]
  37. Löwhagen G. B., Tunbäck P., Andersson K., Bergström T., Johannisson G. First episodes of genital herpes in a Swedish STD population: a study of epidemiology and transmission by the use of herpes simplex virus (HSV) typing and specific serology. Sex Transm Infect. 2000 Jun;76(3):179–182. doi: 10.1136/sti.76.3.179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Martins T. B., Woolstenhulme R. D., Jaskowski T. D., Hill H. R., Litwin C. M. Comparison of four enzyme immunoassays with a western blot assay for the determination of type-specific antibodies to herpes simplex virus. Am J Clin Pathol. 2001 Feb;115(2):272–277. doi: 10.1309/RV29-7CCN-5DYW-M4Y6. [DOI] [PubMed] [Google Scholar]
  39. Mertz G. J., Benedetti J., Ashley R., Selke S. A., Corey L. Risk factors for the sexual transmission of genital herpes. Ann Intern Med. 1992 Feb 1;116(3):197–202. doi: 10.7326/0003-4819-116-3-197. [DOI] [PubMed] [Google Scholar]
  40. Mertz G. J., Schmidt O., Jourden J. L., Guinan M. E., Remington M. L., Fahnlander A., Winter C., Holmes K. K., Corey L. Frequency of acquisition of first-episode genital infection with herpes simplex virus from symptomatic and asymptomatic source contacts. Sex Transm Dis. 1985 Jan-Mar;12(1):33–39. doi: 10.1097/00007435-198501000-00007. [DOI] [PubMed] [Google Scholar]
  41. Mills J. Testing for herpes simplex virus type 2: full-steam ahead? Sex Transm Dis. 2000 May;27(5):270–271. doi: 10.1097/00007435-200005000-00006. [DOI] [PubMed] [Google Scholar]
  42. Munday P. E., Vuddamalay J., Slomka M. J., Brown D. W. Role of type specific herpes simplex virus serology in the diagnosis and management of genital herpes. Sex Transm Infect. 1998 Jun;74(3):175–178. doi: 10.1136/sti.74.3.175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Nahmias A. J., Lee F. K., Beckman-Nahmias S. Sero-epidemiological and -sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis Suppl. 1990;69:19–36. [PubMed] [Google Scholar]
  44. Persson K., Månsson A., Jönsson E., Nordenfelt E. Decline of herpes simplex virus type 2 and Chlamydia trachomatis infections from 1970 to 1993 indicated by a similar change in antibody pattern. Scand J Infect Dis. 1995;27(3):195–199. doi: 10.3109/00365549509019008. [DOI] [PubMed] [Google Scholar]
  45. Prince H. E., Ernst C. E., Hogrefe W. R. Evaluation of an enzyme immunoassay system for measuring herpes simplex virus (HSV) type 1-specific and HSV type 2-specific IgG antibodies. J Clin Lab Anal. 2000;14(1):13–16. doi: 10.1002/(SICI)1098-2825(2000)14:1&#x0003c;13::AID-JCLA3&#x0003e;3.0.CO;2-C. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Prober C. G., Corey L., Brown Z. A., Hensleigh P. A., Frenkel L. M., Bryson Y. J., Whitley R. J., Arvin A. M. The management of pregnancies complicated by genital infections with herpes simplex virus. Clin Infect Dis. 1992 Dec;15(6):1031–1038. doi: 10.1093/clind/15.6.1031. [DOI] [PubMed] [Google Scholar]
  47. Saville M., Brown D., Burgess C., Perry K., Barton S., Cowan F., Palu G., Mengoli C. An evaluation of near patient tests for detecting herpes simplex virus type-2 antibody. Sex Transm Infect. 2000 Oct;76(5):381–382. doi: 10.1136/sti.76.5.381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Schmid D. S., Brown D. R., Nisenbaum R., Burke R. L., Alexander D., Ashley R., Pellett P. E., Reeves W. C. Limits in reliability of glycoprotein G-based type-specific serologic assays for herpes simplex virus types 1 and 2. J Clin Microbiol. 1999 Feb;37(2):376–379. doi: 10.1128/jcm.37.2.376-379.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Scoular A., Kinghorn G. British Co-operative Clinical Group national survey on diagnostic issues surrounding genital herpes. MSSVD Special Interest Group on Genital Herpes and the British Co-operative Clinical Group. Sex Transm Infect. 1999 Dec;75(6):403–405. doi: 10.1136/sti.75.6.403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Slomka M. J., Ashley R. L., Cowan F. M., Cross A., Brown D. W. Monoclonal antibody blocking tests for the detection of HSV-1- and HSV-2-specific humoral responses: comparison with western blot assay. J Virol Methods. 1995 Sep;55(1):27–35. doi: 10.1016/0166-0934(95)00042-s. [DOI] [PubMed] [Google Scholar]
  51. Smith A., Denham I., Keogh L., Jacobs D., McHarg V., Marceglia A., Wood V. Psychosocial impact of type-specific herpes simplex serological testing on asymptomatic sexual health clinic attendees. Int J STD AIDS. 2000 Jan;11(1):15–20. doi: 10.1258/0956462001914841. [DOI] [PubMed] [Google Scholar]
  52. Stanberry L. R. Asymptomatic herpes simplex virus shedding and Russian roulette. Clin Infect Dis. 2000 Feb;30(2):268–269. doi: 10.1086/313681. [DOI] [PubMed] [Google Scholar]
  53. Svennerholm B., Olofsson S., Jeansson S., Vahlne A., Lycke E. Herpes simplex virus type-selective enzyme-linked immunosorbent assay with Helix pomatia lectin-purified antigens. J Clin Microbiol. 1984 Feb;19(2):235–239. doi: 10.1128/jcm.19.2.235-239.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Sánchez-Martínez D., Schmid D. S., Whittington W., Brown D., Reeves W. C., Chatterjee S., Whitley R. J., Pellett P. E. Evaluation of a test based on baculovirus-expressed glycoprotein G for detection of herpes simplex virus type-specific antibodies. J Infect Dis. 1991 Dec;164(6):1196–1199. doi: 10.1093/infdis/164.6.1196. [DOI] [PubMed] [Google Scholar]
  55. Vyse A. J., Gay N. J., Slomka M. J., Gopal R., Gibbs T., Morgan-Capner P., Brown D. W. The burden of infection with HSV-1 and HSV-2 in England and Wales: implications for the changing epidemiology of genital herpes. Sex Transm Infect. 2000 Jun;76(3):183–187. doi: 10.1136/sti.76.3.183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Wald A. New therapies and prevention strategies for genital herpes. Clin Infect Dis. 1999 Jan;28 (Suppl 1):S4–13. doi: 10.1086/514723. [DOI] [PubMed] [Google Scholar]
  57. Woolley P. D., Chandiok S., Pumphrey J., Sharratt S., Shanley L., Bennett S. Serological prevalence of herpes simplex virus type 2 amongst GUM clinic attenders in a district general hospital setting. Int J STD AIDS. 2000 Jun;11(6):379–382. doi: 10.1258/0956462001916092. [DOI] [PubMed] [Google Scholar]

Articles from Sexually Transmitted Infections are provided here courtesy of BMJ Publishing Group

RESOURCES